Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
Year
336 results
-
Australian Respiratory Surveillance Report – 5 May to 18 May 2025
This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus. -
Australian Respiratory Surveillance Report – 21 April to 4 May 2025
This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus. -
Australian Respiratory Surveillance Report – 7 April to 20 April 2025
This fortnightly Australian Respiratory Surveillance Report (ARSR) includes information about acute respiratory illnesses including COVID-19, influenza and respiratory syncytial virus. -
Letter to aged care providers about COVID-19 vaccinations ahead of the festive season
Read our letter to aged care providers about increasing COVID-19 vaccinations and maintaining infection prevention and control measures ahead of the festive season. -
Coronavirus (COVID-19) – Use of Paxlovid (nirmatrelvir + ritonavir) in residential aged care
This fact sheet outlines the key considerations of introducing Paxlovid® (nirmatrelvir + ritonavir) into residential aged care clinical practices. -
Vaccine Administration Error (VAE) reporting form
This form is to help vaccine providers report a vaccine administration error under the COVID-19 Vaccination Program. -
ATAGI clinical guidance on COVID-19 vaccine administration errors
These guidelines from the Australian Technical Advisory Group on Immunisation (ATAGI) provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended. -
Coronavirus (COVID-19) – CDNA National Guidelines for Public Health Units
These guidelines for Public Health Units provide nationally consistent guidance on how to respond to coronavirus (COVID-19). They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA). -
Aged care COVID-19 vaccination – Communication toolkit
This toolkit provides information and material to communicate with older people, particularly aged care residents, their families and carers, about COVID-19 vaccines and oral antiviral treatments. -
Vaccine Administration Partners Program – Enterprise order request (EOR)
Immunisation providers (IProviders) must provide an Enterprise Order Request to us. The Enterprise Order Request will become an Enterprise Order when we approve it. -
COVID-19 information for Board Chairs of Residential Aged Care Providers
A joint letter on winter outbreaks to Board Chairs, Residential Aged Care Providers from the Chief Medical Officer, Professor Paul Kelly and Aged Care Quality and Safety Commissioner, Janet Anders. -
59:00
2024 flu season and respiratory illnesses
This webinar recording will inform vaccination providers about the upcoming 2024 flu season and respiratory illnesses.
-
Cold Chain Breach (CCB) reporting form
This form is to help vaccine providers report a potential cold chain breach under the COVID-19 vaccination program. -
Support Portal for providers reporting a COVID-19 outbreak or exposure in residential aged care
Describes the steps to report a COVID-19 outbreak or exposure in residential aged care. -
Planning checklist for COVID-19 vaccination day in residential aged care homes
A checklist to help residential aged care home get ready for COVID-19 vaccination day. -
COVID-19 oral treatments – Information for residents in residential aged care homes and their families
This fact sheet outlines how and when oral treatments for COVID-19 will be administered in residential aged care homes on oral treatments. -
COVID-19 vaccination – Shared decision making guide for women who are pregnant, breastfeeding or planning pregnancy
This decision guide to COVID-19 vaccination is for women who are pregnant, breastfeeding or planning pregnancy. -
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
This guide provides information on pericarditis and myocarditis following COVID-19 vaccines. -
ATAGI guidance on the use of multi-dose vials for COVID-19 vaccination
The Australian Technical Advisory Group on Immunisation (ATAGI) have developed guidance for the correct use of multi-dose vials and are provided in the context of the COVID-19 pandemic to minimise the risks of vial contamination, administration errors and vaccine wastage. -
Coronavirus (COVID-19) cleaning and disinfection for health and residential aged care homes
An information sheet with guidance about environmental cleaning and disinfection principles for health facilities and residential aged care homes for coronavirus (COVID-19). -
Aged care COVID-19 supports update – Webinar presentation slides – 23 October 2023
In this webinar, we provided the aged care sector with an update on the Australian Government aged care COVID-19 outbreak management supports. We also provided an update on ATAGI advice on the additional vaccination dose, IPC lead nurse evaluation, PPE deployment and grants. -
54:57
Aged care COVID-19 supports update – Webinar recording – 23 October 2023
In this webinar recording, we provided the aged care sector with an update on the Australian Government aged care COVID-19 outbreak management supports. We also provided an update on ATAGI advice on the additional vaccination dose, IPC lead nurse evaluation, PPE deployment and grants. -
Advisory Committee for the COVID-19 Response for People with Disability – Summary of outcomes 3 April 2023
This communique provides a summary of the advisory committee's meeting on 3 April 2023. -
5:40
Supporting people with disability to access COVID-19 vaccination – for disability support providers
This video is for disability providers and explains how you can support people with disability to access COVID-19 vaccination. -
Prescriptions via telehealth – state and territory rules
Arrangements for image-based prescribing implemented at the start of the COVID-19 pandemic will cease on 31 March 2023 in all settings. Electronic prescribing is now widely available in Australia and provides an option for supporting telehealth consultations and enabling supply of medicines.